Logo

Fresh hope for type 1 diabetes as daily pill that slows onset confirms promise at two-year follow-up

Fresh hope for type 1 diabetes as daily pill that slows onset confirms promise at two-year follow-up

In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial reported that a daily pill of baricitinib, commonly prescribed for rheumatoid arthritis and alopecia, could safely preserve the body's own insulin production and slow the progression of type 1 diabetes (T1D) in people recently diagnosed with the condition.

👉 Full Story